Please assess the completion status of the following clinical trial:

Trial Title: Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Currently being treated on an outpatient basis~* Currently attending school~* Diagnosis of non-psychotic major depressive disorder (MDD)~* Duration of illness is at least 4 weeks~* In good general medical health~* Normal intelligence~Exclusion Criteria:~* Lifetime history of any psychotic disorder, including psychotic depression~* Diagnosis of bipolar I or II disorder~* History of alcohol or substance abuse or dependence within 6 months of study entry~* Lifetime history of anorexia nervosa or bulimia~* Pregnant or breastfeeding~* Does not agree to use an effective form of contraception (i.e., IUD, birth control pills, or barrier devices)~* Any chronic medical illness requiring regular medication~* Currently taking medication with psychotropic effects (i.e., anticonvulsants, steroids, etc.), other than stable stimulant treatment~* A first degree relative has bipolar I disorder~* Previous adequate treatment with fluoxetine was ineffective (defined as at least 20 mg/day for 4 weeks)

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).